Moreover, post-hoc analyses of the Copenhagen General Population Study (CGPS) and the Copenhagen City Heart Study (CCHS), which measured plasma Lp(a) levels, along with LPA KIV type 2 number of repeats and the SNP LPA rs10455872, which represent key genetic determinants of circulating Lp(a) levels in the Danish general population, revealed that individuals with Lp(a) levels in the top 5% of the concentration distribution presented a 60% higher risk of ischemic stroke and a 17% higher absolute 10-year risk of stroke compared to those with lower Lp(a) values [37]. The gene discussed is LPA; the disease is ischemic stroke.